Insider · CIK 0001219384

GIVEN BRUCE D

Reports to the SEC for 2 companies · PASADENA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001219384

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+500 sh	$7.75	+$3,875	852,134
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−213 sh	—	—	329,347
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−830 sh	—	—	329,560
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,200 sh	—	—	330,390
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−1,454 sh	—	—	331,590
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−500 sh	—	—	333,044
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−700 sh	$40.00	−$28K	850,730
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−204 sh	$40.00	−$8,160	851,430
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−213 sh	$40.00	−$8,520	851,634
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−830 sh	$40.00	−$33.2K	851,847
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−1,200 sh	$40.00	−$48K	852,677
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−1,454 sh	$40.00	−$58.2K	853,877
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−500 sh	$40.00	−$20K	855,331
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+213 sh	$5.20	+$1,107.6	855,831
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+830 sh	$5.19	+$4,307.7	855,618
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,200 sh	$4.75	+$5,700	854,788
2020-04-28	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+1,454 sh	$14.54	+$21.1K	853,588
2020-04-27	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−200 sh	$40.00	−$8,000	851,734
2020-04-27	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+200 sh	$5.19	+$1,038	851,934
2020-04-27	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−100 sh	$40.00	−$4,000	851,634
2020-04-27	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−200 sh	—	—	333,544
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,700 sh	—	—	342,500
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,300 sh	—	—	333,744
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−3,454 sh	$40.00	−$138K	855,539
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−5,300 sh	$40.00	−$212K	858,993
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−3,456 sh	$40.00	−$138K	864,293
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−3,700 sh	$40.00	−$148K	867,749
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−3,800 sh	$40.00	−$152K	871,449
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,300 sh	$14.54	+$77.1K	875,249
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,456 sh	$5.20	+$18K	869,949
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,700 sh	$5.19	+$19.2K	866,493
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+3,800 sh	$4.75	+$18.1K	862,793
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−3,805 sh	$40.00	−$152K	851,734
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,800 sh	—	—	346,200
2020-04-20	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−3,456 sh	—	—	339,044
2020-01-06	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−1,300 sh	$60.99	−$79.3K	858,993
2020-01-06	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−11.8K sh	$59.57	−$706K	882,759
2020-01-06	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−22.5K sh	$60.37	−$1.36M	860,293
2020-01-01	ARWRARROWHEAD PHARMACEUTICALS, INC.A Award	Chief Operating Officer	AAward	+250K sh	—	—	894,606
2019-03-01	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−42.5K sh	—	—	350,000
2019-03-01	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+42.5K sh	$2.01	+$85.4K	687,106
2019-03-01	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−42.5K sh	$19.99	−$850K	644,606
2019-02-25	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+42.5K sh	$2.01	+$85.4K	687,106
2019-02-25	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−42.5K sh	—	—	392,500
2019-02-25	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−42.5K sh	$18.98	−$807K	644,606
2019-02-19	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−42.5K sh	$17.98	−$764K	644,606
2019-02-19	ARWRARROWHEAD PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+42.5K sh	$2.01	+$85.4K	687,106
2019-02-19	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−42.5K sh	—	—	435,000
2019-02-15	ARWRARROWHEAD PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−26.3K sh	$17.67	−$464K	644,606
2019-02-12	ARWRARROWHEAD PHARMACEUTICALS, INC. · Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−42.5K sh	—	—	477,500

Recent filings

Accepted (ET)
Apr 294
GIVEN BRUCE D0001209191-20-026230
SEC(opens sec.gov)

Companies

Address

225 SOUTH LAKE AVNEUE, SUITE 300

PASADENA, CA, 91101